Latest Ratios: P/E Ratio -31.8x · EV/EBITDA N/A · ROE -29.4%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $1.1B | $227M | — | — | — | — |
| Enterprise Value | $975M | $88M | — | — | — | — |
| P/E Ratio → | -31.82 | — | — | — | — | — |
| P/S Ratio | 9.46 | 3.14 | — | — | — | — |
| P/B Ratio | 2.25 | 1.40 | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.21 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 35.4% | 35.4% | 31.9% | 29.7% | 33.8% | 42.3% |
| Operating Margin | -56.7% | -56.7% | -53.4% | -78.3% | -27.6% | -39.7% |
| Net Profit Margin | -50.3% | -50.3% | -52.1% | -76.8% | -27.8% | -49.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -29.4% | -29.4% | -54.7% | -68.0% | -28.0% | -27.3% |
| ROA | -25.2% | -25.2% | -44.9% | -56.7% | -24.7% | -25.3% |
| ROIC | -127.0% | -127.0% | -104.0% | -80.3% | -41.7% | -55.6% |
| ROCE | -31.9% | -31.9% | -53.4% | -68.5% | -27.3% | -21.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.01 | 0.02 | — | — |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.86 | -0.70 | -0.44 | -0.29 | -0.70 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -4.42 |
Net cash position: cash ($140M) exceeds total debt ($678000)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 8.72 | 8.72 | 7.56 | 4.94 | 6.68 | 15.59 |
| Quick Ratio | 7.84 | 7.84 | 6.28 | 3.28 | 4.40 | 14.36 |
| Cash Ratio | 7.31 | 7.31 | 5.18 | 2.12 | 1.75 | 10.70 |
| Asset Turnover | — | 0.39 | 0.73 | 0.90 | 0.87 | 0.51 |
| Inventory Turnover | 2.76 | 2.76 | 3.45 | 2.15 | 1.79 | 3.95 |
| Days Sales Outstanding | — | 36.67 | 49.91 | 68.36 | 82.97 | 78.73 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $8M | $14M | $10M | $249M | $14M |
Includes 30+ ratios · 5 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMBQ stock.
Ambiq Micro, Inc.'s current P/E ratio is -31.8x. This places it at the 50th percentile of its historical range.
Ambiq Micro, Inc.'s return on equity (ROE) is -29.4%. The historical average is -41.5%.
Based on historical data, Ambiq Micro, Inc. is trading at a P/E of -31.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Ambiq Micro, Inc. has 35.4% gross margin and -56.7% operating margin.
Key Metrics
Top Statement Risk
Persistent operating losses and thin gross margins
Metrics are mathematically derived from official filings.
Margin Expansion Still Lags Scale
Gross margin improved to 45.0% in 2026Q2 from 17.2% in 2024Q4, yet TTM operating margin remains deeply negative at -56.7%, indicating fixed costs still outpace gross profit, as per financial statements.
The sequential gross margin expansion from 40.1% in 2025Q2 to 45.0% in 2026Q2 suggests improving product mix or pricing power, but the operating margin of -25.7% in 2026Q2, while better than -65.7% in 2025Q1, still reflects R&D and SG&A spend exceeding gross profit. This implies that even with the recent revenue surge, the company has not yet achieved the scale needed to cover its high fixed-cost structure. Investors should monitor whether gross margin can sustain above 45% as volumes grow, as the current level remains below the peer average of 53.6%, suggesting structural cost disadvantages.
Return on Capital Still Deeply Negative
ROIC improved to -17.4% in 2026Q2 from -38.2% in 2025Q4, but remains far below cost of capital, indicating value destruction persists despite revenue acceleration, based on reported quarterly data.
The improvement in ROIC is driven primarily by a larger capital base from the recent equity raise, not by operational efficiency, as net operating profit after taxes remains negative. With ROE at -2.2% and ROA at -2.0% in 2026Q2, the company is still burning through invested capital, though at a slower pace. The negative returns suggest that the business is not yet compounding value, and the recent capital infusion may simply extend the runway rather than signal a fundamental turn in capital efficiency.
Working Capital Drag Intensifies
Cash conversion cycle lengthened to 121 days in 2026Q2 from 112 days in 2024Q4, driven by DIO of 129 days, indicating inventory buildup that may strain liquidity if demand falters, as per financial statements.
The inventory days on hand of 129 days in 2026Q2, up from 81 days in 2024Q4, suggests the company is building stock ahead of anticipated demand, which is consistent with the revenue surge but also raises obsolescence risk in the fast-moving wearable market. DSO of 38 days is relatively stable, but the extended DIO and a CCC of 121 days imply that working capital is absorbing cash, contributing to the negative FCF margin of -18.5% in 2026Q2. If the growth trajectory decelerates, this inventory overhang could force write-downs and further pressure margins.
Liquidity Fortress Masks Cash Burn
Current ratio of 15.95 and cash of $366.8M provide ample runway, but quarterly operating cash burn of -$9.5M in 2026Q2 suggests the fortress is being depleted, as reported in the latest balance sheet.
The current ratio of 15.95 in 2026Q2 is exceptionally high, reflecting the recent capital raise, but the company still consumed $9.5M in operating cash in that quarter, indicating that the cash pile will shrink if losses persist. With a quarterly burn rate of roughly $10M, the $366.8M cash balance provides over three years of runway, but this assumes no acceleration in spending. The liquidity position is strong, but it is a temporary buffer, not a sign of self-sustaining operations.
Debt-Free but Equity-Dependent
Debt-to-equity of 0.01 and minimal debt of $4.6M indicate a conservative balance sheet, but the reliance on equity funding suggests dilution risk if losses continue, based on reported figures.
The company's near-zero leverage is a positive, as it avoids interest and refinancing risk, but it also means that all funding comes from equity, which has led to significant dilution. The $366.8M cash balance is largely from a recent capital raise, and with negative retained earnings, the company will likely need additional equity if it cannot reach profitability. The lack of debt provides flexibility, but it also signals that the company cannot service debt, which is consistent with its negative EBITDA.
Gross Margin Misapplied as Profitability Proxy
Gross margin of 45.0% in 2026Q2 may be misread as a sign of profitability, but TTM operating margin of -56.7% reveals that R&D and SG&A costs overwhelm gross profit, as per financial statements.
In semiconductor companies, gross margin is often used as a proxy for competitive advantage, but for Ambiq, the high fixed R&D costs and low asset turnover mean that gross margin does not translate into operating profit. The company's gross margin is below the peer average, and even if it expands to 50%, the operating margin would still be negative given the current cost structure. A more appropriate metric is the operating margin or the contribution margin after R&D, which better reflects the company's ability to generate sustainable earnings. Investors should focus on the path to operating breakeven rather than gross margin alone.